UBS Cuts Price Target on Clorox (CLX) to $111 Following 1Q EPS Miss
- Top 10 News for 12/2: Crude Rips on OPEC Cut; Starbucks' Schultz Steps Down; Nonfarm Payrolls Flat in Nov.
- Unemployment Rate Drops to 4.6%
- Bond yields slip on U.S. jobs data, euro steady before Italy vote
- Alibaba (BABA) Founder Jack Ma Discuss Plans to Retire; 'I Don't Want to Die at the Office'
- Starbucks Coffee (SBUX) CEO Howard Schultz to Step Down, Appointed Executive Chairman; Kevin Johnson New CEO
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
UBS maintained a Sell rating on Clorox (NYSE: CLX), and cut the price target to $111.00 (from $118.00), following the company's 1Q earnings report. CLX missed EPS, reporting $1.36 compared to consensus of $1.42. CLX lowered FY17 EPS guidance to $5.23-$5.43 (from $5.38-$5.58 prior).
Analyst Stephen Powers commented, "For the second consecutive quarter, CLX missed EPS (delivering Q1:17 EPS of $1.36 vs. UBSe/cons. of $1.41/$1.42). Revenues grew +4.0% (vs. UBSe/cons. of +3.2%/+2.8%) and +6.0% FX-neutral (vs. UBSe +5.5%) on strong volumes (+8.0%) and help from M&A (a ~+2.0% contribution from Renew Life)—however, weaker gross margins (-61 bps vs. of UBSe +20 bps) and higher taxes (32.2% vs. UBSe of 30.5%) weighed on results. Additionally, CLX lowered FY17 EPS guidance to $5.23-$5.43 (from $5.38-$5.58 prior) as it now expects a lower tax benefit (~$0.15) from the adoption of ASU 2016-09, although it maintained underlying FY17 EPS guidance of $5.13-$5.28."
Shares of Clorox closed at $115.67 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Raises Price Target on Zumiez, Inc. (ZUMZ) to $23 Following 3Q
- Cowen Cuts Price Target on Workday (WDAY) Following 3Q
- Mizuho Securities Cuts Price Target on Express (EXPR) Following 3Q Miss
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change
Related EntitiesUBS, Earnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!